Drug
Aat
Aat: highest development phase Phase 2/3, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| AAT NCT03805789 | Phase 2/3 | Acute-graft-versus-host Disease |
Latest
No recent events.
Follow Aat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.